Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H SFOSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.52
- Day Range
- $1.52–1.53
- 52-Week Range
- $1.52–2.99
- Bid/Ask
- $1.39 / $1.55
- Market Cap
- $4.09 Bil
- Volume/Avg
- 5,820 / 6,212
Key Statistics
- Price/Earnings (Normalized)
- 13.88
- Price/Sales
- 0.70
- Dividend Yield (Trailing)
- 3.83%
- Dividend Yield (Forward)
- 0.49%
- Total Yield
- 3.83%
Company Profile
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Value
- Total Number of Employees
- 40,370
- Website
- https://www.fosunpharma.com
Comparables
Valuation
|
Metric
|
SFOSF
|
600521
|
600568
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.88 | 21.11 | — |
Price/Book Value | 0.64 | 2.76 | 1.06 |
Price/Sales | 0.70 | 2.54 | 5.32 |
Price/Cash Flow | 6.46 | 10.47 | — |
Price/Earnings
SFOSF
600521
600568
Financial Strength
|
Metric
|
SFOSF
|
600521
|
600568
|
|---|---|---|---|
Quick Ratio | — | 0.84 | 2.50 |
Current Ratio | — | 1.63 | 4.18 |
Interest Coverage | — | 6.79 | −70.39 |
Quick Ratio
SFOSF
600521
600568
Profitability
|
Metric
|
SFOSF
|
600521
|
600568
|
|---|---|---|---|
Return on Assets (Normalized) | — | 5.91% | — |
Return on Equity (Normalized) | — | 13.99% | — |
Return on Invested Capital (Normalized) | — | 8.36% | — |
Return on Assets
SFOSF
600521
600568
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Vhygxmlqzz | Cjyx | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Bzgpjzvrf | Pzjfq | $68.1 Bil | |
HLN
| Haleon PLC ADR | Mzdmphmq | Vgck | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Txlmmxnt | Cgcs | $14.3 Bil | |
VTRS
| Viatris Inc | Rcssmgr | Bjnr | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mdmdynyjy | Xkpqn | $12.0 Bil | |
CTLT
| Catalent Inc | Nbqtvgnq | Zylmfcw | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Npcbzls | Plkx | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Cybzztwkt | Wzxq | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Kwxpmvg | Gsmxp | $3.4 Bil |